The Use of Nanoparticles to Guide the Surgical Treatment of Prostate Cancer — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

The Use of Nanoparticles to Guide the Surgical Treatment of Prostate Cancer — Stella

Recruiting

Back to Prostate Cancer trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(2 sites)

United States

Memorial Sloan Kettering Cancer Center, New York, New York

Weill Cornell Medicine, New York, New York

Key details

Phase

Early testing

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

Cornell University/Weill Cornell Medical Center, National Cancer Institute (NCI)

Enrollment target

~16 participants

Started

February 2021

Primary completion

November 2026

Age range

18 Years and older

Sex

Male only

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov